XML 85 R57.htm IDEA: XBRL DOCUMENT
v3.25.2

SHARE CAPITAL - Summary of warrants by expiry period (Details) - Common Share Purchase Warrants $ / shares in Units, $ in Thousands | Mar. 31, 2025 CAD ($) shares $ / shares | Mar. 31, 2024 shares | Mar. 31, 2023 shares
--- | --- | --- | ---
Disclosure of classes of share capital [line items] |  |  |
Warrants outstanding (in shares) | 2,796,197 | 2,796,197 | 611,329
Warrants exercisable (in shares) | 2,796,197 |  |
Weighted average of exercisable price (in CAD per share) | $ / shares | $ 24.03 |  |
Estimated grant date fair value | $ | $ 27,594 |  |
Weighted average remaining of outstanding contractual life | 4 years 1 month 9 days |  |
August 4, 2028 |  |  |
Disclosure of classes of share capital [line items] |  |  |
Warrants outstanding (in shares) | 635,887 |  |
Warrants exercisable (in shares) | 635,887 |  |
Weighted average of exercisable price (in CAD per share) | $ / shares | $ 15.2 |  |
Estimated grant date fair value | $ | $ 4,578 |  |
Weighted average remaining of outstanding contractual life | 3 years 4 months 6 days |  |
May 14, 2029 |  |  |
Disclosure of classes of share capital [line items] |  |  |
Warrants outstanding (in shares) | 1,754,386 |  |
Warrants exercisable (in shares) | 1,754,386 |  |
Weighted average of exercisable price (in CAD per share) | $ / shares | $ 19.38 |  |
Estimated grant date fair value | $ | $ 17,842 |  |
Weighted average remaining of outstanding contractual life | 4 years 1 month 13 days |  |
June 15, 2030 |  |  |
Disclosure of classes of share capital [line items] |  |  |
Warrants outstanding (in shares) | 336,843 |  |
Warrants exercisable (in shares) | 336,843 |  |
Weighted average of exercisable price (in CAD per share) | $ / shares | $ 9.50 |  |
Estimated grant date fair value | $ | $ 3,891 |  |
Weighted average remaining of outstanding contractual life | 5 years 2 months 15 days |  |
August 20, 2030 |  |  |
Disclosure of classes of share capital [line items] |  |  |
Warrants outstanding (in shares) | 38,818 |  |
Warrants exercisable (in shares) | 38,818 |  |
Weighted average of exercisable price (in CAD per share) | $ / shares | $ 24.32 |  |
Estimated grant date fair value | $ | $ 936 |  |
Weighted average remaining of outstanding contractual life | 5 years 4 months 20 days |  |
November 15, 2030 |  |  |
Disclosure of classes of share capital [line items] |  |  |
Warrants outstanding (in shares) | 30,263 |  |
Warrants exercisable (in shares) | 30,263 |  |
Weighted average of exercisable price (in CAD per share) | $ / shares | $ 9.50 |  |
Estimated grant date fair value | $ | $ 347 |  |
Weighted average remaining of outstanding contractual life | 5 years 7 months 17 days |  |

X
- Definition Weighted Average Remaining Contractual Life of Other Equity Instruments + References No definition available. + Details
Name: | cybn_WeightedAverageRemainingContractualLifeOfOtherEquityInstruments
Namespace Prefix: | cybn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cybn_CommonSharePurchaseWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_WarrantExpirationPeriodAxis=cybn_WarrantExpirationPeriodOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_WarrantExpirationPeriodAxis=cybn_WarrantExpirationPeriodTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_WarrantExpirationPeriodAxis=cybn_WarrantExpirationPeriodThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_WarrantExpirationPeriodAxis=cybn_WarrantExpirationPeriodFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_WarrantExpirationPeriodAxis=cybn_WarrantExpirationPeriodFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |